A candidate glycoconjugate vaccine induces protective antibodies in the serum and intestinal secretions, antibody recall response and memory T cells and protects against both typhoidal and non-typhoidal <i>Salmonella</i> serovars.

Authors:
Haldar R; Dhar A; Ganguli D; Chakraborty S; Pal A and 3 more

Journal:
Front Immunol

Publication Year: 2024

DOI:
10.3389/fimmu.2023.1304170

PMCID:
PMC10804610

PMID:
38264668

Journal Information

Full Title: Front Immunol

Abbreviation: Front Immunol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Allergy and Immunology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest Author GB was employed by company BD Biosciences. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."

Evidence found in paper:

"The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by extramural grants from Indian Council of Medical Research, Government of India (58/17/2020/PHA/BMS) and the Japan Agency for Medical Research and Development (AMED; Grant No. JP23wm0125004)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025